MENU
+Compare
LFCR
Stock ticker: NASDAQ
AS OF
May 22, 11:32 AM (EDT)
Price
$6.45
Change
-$0.00 (-0.00%)
Capitalization
176.87M

LFCR Lifecore Biomedical Forecast, Technical & Fundamental Analysis

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials... Show more

LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for LFCR with price predictions
May 21, 2025

Aroon Indicator for LFCR shows an upward move is likely

LFCR's Aroon Indicator triggered a bullish signal on May 13, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 177 similar instances where the Aroon Indicator showed a similar pattern. In of the 177 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The 10-day moving average for LFCR crossed bullishly above the 50-day moving average on April 25, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LFCR advanced for three days, in of 285 cases, the price rose further within the following month. The odds of a continued upward trend are .

LFCR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on May 14, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on LFCR as a result. In of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for LFCR turned negative on May 15, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

LFCR moved below its 50-day moving average on May 21, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LFCR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LFCR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.789) is normal, around the industry mean (61.157). P/E Ratio (0.000) is within average values for comparable stocks, (88.912). Projected Growth (PEG Ratio) (2.661) is also within normal values, averaging (2.987). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (1.680) is also within normal values, averaging (18.928).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LFCR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

LFCR is expected to report earnings to fall 92.55% to -3 cents per share on August 27

Lifecore Biomedical LFCR Stock Earnings Reports
Q2'25
Est.
$-0.04
Q1'25
Missed
by $0.33
Q4'24
Beat
by $0.02
Q3'24
Missed
by $0.04
Q2'24
Missed
by $0.04
The last earnings report on April 03 showed earnings per share of -46 cents, missing the estimate of -14 cents. With 7.51K shares outstanding, the current market capitalization sits at 176.87M.
A.I. Advisor
published General Information

General Information

a manufacturer of polymer products for food and agricultural products, medical devices and licensed partner applications

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Industrial Specialties
Address
3515 Lyman Boulevard
Phone
+1 952 368-4300
Employees
459
Web
https://www.lifecore.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BUIMX16.72N/A
N/A
Buffalo Mid Cap Growth Inst
BAEIX21.89N/A
N/A
Sterling Capital Equity Income A
GICUX14.51N/A
N/A
Goldman Sachs Intl Sm Cp Insghts R6
SUIRX56.61N/A
N/A
DWS CROCI International R6
SUGCX12.78N/A
N/A
Victory Pioneer Global Growth C

LFCR and Stocks

Correlation & Price change

A.I.dvisor tells us that LFCR and SHPH have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LFCR and SHPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
-2.71%
SHPH - LFCR
31%
Poorly correlated
-7.23%
ALKS - LFCR
27%
Poorly correlated
-3.60%
OGI - LFCR
27%
Poorly correlated
-0.74%
AMRX - LFCR
27%
Poorly correlated
-2.02%
TLRY - LFCR
27%
Poorly correlated
-4.42%
More